For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
Liminatus Pharma Inc (NASDAQ: LIMN) closed the day trading at $3.4 down -0.29% from the previous closing price of $3.41. In other words, the price has decreased by -$0.29 from its previous closing price. On the day, 1.58 million shares were traded. LIMN stock price reached its highest trading level at $3.5998 during the session, while it also had its lowest trading level at $2.9325.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, LIMN now has a Market Capitalization of 92019640.
Stock Price History:
The Beta on a monthly basis for LIMN is 0.47, which has changed by -0.57711446 over the last 52 weeks, in comparison to a change of 0.14460516 over the same period for the S&P500. Over the past 52 weeks, LIMN has reached a high of $33.66, while it has fallen to a 52-week low of $2.53. The 50-Day Moving Average of the stock is -57.28%, while the 200-Day Moving Average is calculated to be -65.35%.
Shares Statistics:
Over the past 3-months, LIMN traded about 1.22M shares per day on average, while over the past 10 days, LIMN traded about 4193470 shares per day. A total of 26.01M shares are outstanding, with a floating share count of 5.56M. Insiders hold about 79.47% of the company’s shares, while institutions hold 0.76% stake in the company. Shares short for LIMN as of 1753920000 were 230060 with a Short Ratio of 0.19, compared to 1751241600 on 174194.
